Food and Drug Administration: Center for Biologics Evaluation and Research (Bethesda, Maryland)
April 19, 2002
Robin J. Strongin, Consultant
This one-day site visit was designed to expose nonscientists to some of the cutting-edge biomedical advances being made at the Food and Drug Administration's Center for Biologics Evaluation and Research (CBER), located on the National Institutes of Health campus in Bethesda, Maryland. Site visitors heard presentations on CBER's current and future mandates, the approval process for biologics, resources and the reauthorization of the Prescription Drug User Fee Act, vaccines, stem cells and tissues, blood safety, generic biologics, and clinical proteomics. They also toured vaccine, clinical proteomics, and blood safety laboratories.
No report was produced for this site visit.